🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Split 2:1 del 28/01/2013

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

6.181.783

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 3 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
14/09/2022 0,7300 USD
14/06/2022 0,7300 USD
14/03/2022 0,7300 USD
14/12/2021 0,7100 USD
14/09/2021 0,7100 USD
14/06/2021 0,7100 USD
12/03/2021 0,7100 USD
14/12/2020 0,6800 USD
14/09/2020 0,6800 USD
11/06/2020 0,6800 USD
12/03/2020 0,6800 USD
12/12/2019 0,6300 USD
12/09/2019 0,6300 USD
13/06/2019 0,6300 USD
14/03/2019 0,6300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
28/01/2013 2:1
25/06/2007 2:1
07/09/2004 2:1
08/03/2002 2:1
22/02/2001 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/06/2012 24,95 25,34 24,83 25,26 +1,20% 2,04% 11.571.400
21/06/2012 25,48 25,67 24,92 24,96 -1,69% 2,92% 10.058.800
20/06/2012 25,43 25,61 25,19 25,39 +0,10% 1,65% 8.195.000
19/06/2012 25,19 25,53 25,13 25,37 +1,04% 1,59% 8.924.400
18/06/2012 25,18 25,24 24,97 25,11 -0,16% 1,09% 8.566.000
15/06/2012 25,04 25,19 24,97 25,15 +0,40% 0,90% 14.875.000
14/06/2012 24,67 25,08 24,61 25,05 +1,97% 1,93% 12.478.400
13/06/2012 24,75 25,13 24,55 24,56 -0,61% 2,34% 9.520.400
12/06/2012 24,72 24,81 24,40 24,71 -0,24% 1,66% 7.200.600
11/06/2012 24,82 24,95 24,72 24,77 -0,20% 0,93% 8.479.400
08/06/2012 24,45 24,91 24,41 24,82 +1,31% 2,04% 7.522.000
07/06/2012 24,88 24,95 24,50 24,50 -0,45% 1,79% 7.104.400
06/06/2012 24,28 24,70 24,26 24,61 +1,46% 1,79% 8.403.600
05/06/2012 24,50 24,60 24,12 24,26 -1,42% 1,96% 13.695.600
04/06/2012 24,34 24,70 24,24 24,61 +1,11% 1,91% 9.012.200
01/06/2012 24,70 24,80 24,18 24,34 -2,56% 2,51% 11.261.000
31/05/2012 25,20 25,26 24,80 24,98 -1,09% 1,81% 13.342.600
30/05/2012 25,32 25,42 25,09 25,25 -0,90% 1,28% 11.467.600
29/05/2012 25,43 25,56 25,25 25,48 +0,93% 1,22% 9.108.000
25/05/2012 25,37 25,38 25,09 25,25 -0,26% 1,14% 5.765.200
24/05/2012 25,07 25,36 25,01 25,31 +0,84% 1,38% 5.950.000
23/05/2012 25,11 25,21 24,88 25,10 -0,53% 1,31% 9.576.000
22/05/2012 25,47 25,47 25,11 25,24 -0,83% 1,43% 8.592.200
21/05/2012 25,02 25,46 25,00 25,45 +1,90% 1,84% 11.385.800
18/05/2012 25,19 25,19 24,86 24,97 -0,32% 1,33% 15.807.800
17/05/2012 25,78 25,90 25,05 25,05 -2,87% 3,28% 16.547.400
16/05/2012 25,93 26,06 25,79 25,79 -0,56% 1,04% 13.440.000
15/05/2012 26,16 26,18 25,84 25,94 -1,12% 1,32% 12.099.400
14/05/2012 25,83 26,53 25,63 26,23 +1,20% 3,50% 18.509.400
11/05/2012 26,12 26,12 25,60 25,92 +1,15% 2,01% 19.139.800